leukemia, chronic myelogenous
Showing 1 - 2 of 2
Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)
Recruiting
- Leukemia, Chronic Myelogenous
- asciminib
- best available treatment
-
Chongqing City, Chongqing, China
- +23 more
Jan 18, 2023
Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)
Completed
- Leukemia, Chronic Myelogenous
-
Toyoake-City, Aichi, Japan
- +20 more
Apr 26, 2022